Bamco Inc. NY purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 313,262 shares of the business services provider’s stock, valued at approximately $25,904,000.
Other hedge funds have also bought and sold shares of the company. Parkside Financial Bank & Trust boosted its stake in shares of Exponent by 8.7% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,595 shares of the business services provider’s stock worth $140,000 after acquiring an additional 127 shares during the period. Retirement Systems of Alabama increased its holdings in Exponent by 0.3% during the 1st quarter. Retirement Systems of Alabama now owns 63,568 shares of the business services provider’s stock worth $5,256,000 after purchasing an additional 167 shares during the period. Natixis Investment Managers International boosted its position in Exponent by 18.5% during the 1st quarter. Natixis Investment Managers International now owns 1,138 shares of the business services provider’s stock valued at $94,000 after acquiring an additional 178 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in Exponent by 0.5% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 38,341 shares of the business services provider’s stock valued at $3,165,000 after acquiring an additional 206 shares in the last quarter. Finally, Parallel Advisors LLC boosted its position in Exponent by 12.4% during the 4th quarter. Parallel Advisors LLC now owns 1,941 shares of the business services provider’s stock valued at $171,000 after acquiring an additional 214 shares in the last quarter. Institutional investors own 92.37% of the company’s stock.
Insider Buying and Selling
In related news, Director Paul R. Johnston sold 7,000 shares of Exponent stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $93.95, for a total value of $657,650.00. Following the sale, the director now directly owns 79,236 shares in the company, valued at approximately $7,444,222.20. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Paul R. Johnston sold 7,000 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $93.95, for a total transaction of $657,650.00. Following the transaction, the director now directly owns 79,236 shares in the company, valued at approximately $7,444,222.20. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Eric Guyer sold 1,650 shares of the business’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the transaction, the insider now owns 1,846 shares in the company, valued at $170,902.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,067 shares of company stock worth $4,734,995. Insiders own 2.10% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on EXPO
Exponent Trading Down 0.6 %
Shares of NASDAQ EXPO traded down $0.62 during trading on Friday, reaching $105.45. 359,737 shares of the company traded hands, compared to its average volume of 190,804. Exponent, Inc. has a 12-month low of $64.61 and a 12-month high of $108.00. The firm’s fifty day simple moving average is $97.16 and its 200 day simple moving average is $88.42. The stock has a market cap of $5.35 billion, a P/E ratio of 53.26 and a beta of 0.65.
Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.07. Exponent had a return on equity of 29.01% and a net margin of 19.35%. The firm had revenue of $132.43 million during the quarter, compared to analyst estimates of $130.83 million. During the same quarter in the previous year, the business earned $0.50 EPS. Exponent’s revenue for the quarter was up 2.1% compared to the same quarter last year. As a group, research analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be paid a $0.28 dividend. The ex-dividend date is Friday, September 6th. This represents a $1.12 annualized dividend and a dividend yield of 1.06%. Exponent’s dividend payout ratio is presently 56.57%.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- When to Sell a Stock for Profit or Loss
- Is Crypto Cool Again? What Stocks You Should Be Watching
- What Are the FAANG Stocks and Are They Good Investments?
- Why Call Options Volume for These 2 Stocks Spiked Together
- 5 Top Rated Dividend Stocks to Consider
- MarketBeat Week in Review – 7/22 – 7/26
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.